Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)